# Bioequivalence of Ezetimibe Tablets in Healthy Subjects

> **NCT04814589** · PHASE1 · UNKNOWN · sponsor: **Cao Yu** · enrollment: 96 (estimated)

## Conditions studied

- Therapeutic Equivalency

## Interventions

- **DRUG:** ezetimibe tablets
- **DRUG:** ezetimibe tablets(Ezetrol ®)

## Key facts

- **NCT ID:** NCT04814589
- **Lead sponsor:** Cao Yu
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-13
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-07-31
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2021-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04814589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04814589, "Bioequivalence of Ezetimibe Tablets in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04814589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*